The South African Health Products Regulatory Authority (SAHPRA) announced on Monday the registration of the Janssen Covid-19 vaccine on March 31, with conditions. SAHPRA CEO Dr Boitumelo Semete-Makokotlela explained that one of the conditions is that the vaccine be manufactured under conditions of Good Manufacturing Practices (GMP) as determined by SAHPRA and aligned with global best practice.
News
You are here: Home1 / News2 / Industry News3 / SAHPRA registers Janssen Covid-19 vaccine with conditions
You might also like
INDUSTRY NEWS
- South Africa to provide new coal-plant closure timeline to secure secure $2.6bnMay 8, 2024 - 4:04 pm
- Renewables provided record 30% of global electricity in 2023, Ember saysMay 8, 2024 - 11:04 am
- South African company comes second in Milken-Motsepe Prize in Green Energy competitionMay 7, 2024 - 5:04 pm
WHERE TO FIND US
Address
9 Yellow Street
Botshabelo Industrial Area
Botshabelo, Free State
Call / Email Us
Tel: +27 (0) 51 534 1651
Email: info@transfix.co.za